Microorganisms and methods for the biosynthesis of fumarate, malate, and acrylate

US11525149B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11525149-B2
Application numberUS-201715600479-A
CountryUS
Kind codeB2
Filing dateMay 19, 2017
Priority dateJun 17, 2008
Publication dateDec 13, 2022
Grant dateDec 13, 2022

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A non-naturally occurring eukaryotic or prokaryotic organism includes one or more gene disruptions occurring in genes encoding enzymes imparting increased fumarate, malate or acrylate production in the organism when the gene disruption reduces an activity of the enzyme. The one or more gene disruptions confers increased production of acrylate onto the organism. Organisms that produce acrylate have an acrylate pathway that at least one exogenous nucleic acid encoding an acrylate pathway enzyme expressed in a sufficient amount to produce acrylate, the acrylate pathway comprising a decarboxylase. Methods of producing fumarate, malate or acrylate include culturing these organisms.

First claim

Opening claim text (preview).

What is claimed is: 1. A non-naturally occurring eukaryotic microbial organism, comprising one or more endogenous gene disruptions, said one or more gene disruptions occurring in genes encoding enzymes selected from the group consisting of (a) a glycerol-3-phosphate dehydrogenase, a pyruvate decarboxylase, a soluble fumarate reductase, a mitochondrial fumarase, and a cytosolic fumarase; or (b) a malic enzyme, a pyruvate kinase, a soluble fumarate reductase, a mitochondrial fumarase, and a cytosolic fumarase; and wherein said one or more gene disruptions confers enhanced production of malate onto said non-naturally occurring eukaryotic microbial organism compared to a wild-type strain. 2. The non-naturally occurring eukaryotic microbial organism of claim 1 , wherein said organism is in culture medium comprising dissolved oxygen in an amount that is less than 10% of saturation, or wherein said microbial organism is in culture medium wherein the culture medium is in an atmosphere of less than 1% oxygen. 3. The non-naturally occurring eukaryotic microbial organism of claim 1 , wherein said one or more gene disruptions comprises a deletion of said one or more genes. 4. The non-naturally occurring eukaryotic microbial organism of claim 1 , further comprising an endogenous gene disruption of an encoded glucose-6-phosphate dehydrogenase. 5. The non-naturally occurring eukaryotic microbial organism of claim 4 , further comprising an endogenous gene disruption of an encoded cytosolic NADP-dependent isocitrate dehydrogenase. 6. A method for producing malic acid, comprising culturing the non-naturally occurring eukaryotic microbial organism according to claim 1 . 7. The method of claim 6 , wherein said culturing is conducted in a culture medium comprising dissolved oxygen in an amount that is less than 10% of saturation, or wherein said microbial organism is in culture medium wherein the culture medium is in an atmosphere of less than 1% oxygen. 8. The method of claim 6 , wherein said one or more gene disruptions comprises a deletion of said one or more genes. 9. The method of claim 6 , wherein said one or more gene disruptions encode enzymes selected from the group consisting of a glycerol-3-phosphate dehydrogenase, a pyruvate decarboxylase, a soluble fumarate reductase, a mitochondrial fumarase, and a cytosolic fumarase. 10. The method of claim 9 , wherein the non-naturally occurring eukaryotic microbial organism further comprises an endogenous gene disruption of an encoded glucose-6-phosphate dehydrogenase. 11. The method of claim 10 , wherein the non-naturally occurring eukaryotic microbial organism further comprises an endogenous gene disruption of an encoded cytosolic NADP-dependent isocitrate dehydrogenase. 12. The method of claim 6 , wherein said one or more gene disruptions encode enzymes selected from the group consisting of a malic enzyme, a pyruvate kinase, a soluble fumarate reductase, a mitochondrial fumarase, and a cytosolic fumarase.

Assignees

Inventors

Classifications

  • Lyases (4.) · CPC title

  • C12P7/46Primary

    Dicarboxylic acids having four or less carbon atoms, e.g. fumaric acid, maleic acid · CPC title

  • containing a carboxyl group {including Peroxycarboxylic acids} · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11525149B2 cover?
A non-naturally occurring eukaryotic or prokaryotic organism includes one or more gene disruptions occurring in genes encoding enzymes imparting increased fumarate, malate or acrylate production in the organism when the gene disruption reduces an activity of the enzyme. The one or more gene disruptions confers increased production of acrylate onto the organism. Organisms that produce acrylate h…
Who is the assignee on this patent?
Genomatica Inc
What technology area does this patent fall under?
Primary CPC classification C12P7/46. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 13 2022 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).